Michigan Cancer Consortium - Clinical Trials Awareness Month

University of Michigan Comprehensive Cancer Center
www.cancer.med.umich.edu/research/index.shtml
The Cancer Center has 10 multi-disciplinary cancer clinics, providing one-stop access to comprehensive, timely, cost-effective consensus on treatment from a panel of experts. In addition, patients have access to the very latest research. Designation as a Comprehensive Cancer Center by the National Cancer Institute is the most-rigorous and prestigious recognition of the country’s cancer research and treatment centers; there are fewer than 40 in the United States. The designation signifies that the center has met the highest standards for depth and breadth of effort in the following categories of cancer research: basic, clinical, and prevention, control, behavioral, and population-based. Furthermore, the designation signifies that the center exhibits a strong body of interactive research that bridges these scientific areas.

Barbara Ann Karmanos Cancer Institute Comprehensive Cancer Center
www.karmanos.org/app.asp?id=155
The Meyer L. Prentis Comprehensive Cancer Center of Metropolitan Detroit is one of fewer than 40 Comprehensive Cancer Centers in the nation; it is operated by the Barbara Ann Karmanos Cancer Institute. Designation as a Comprehensive Cancer Center by the National Cancer Institute is the most-rigorous and prestigious recognition of the country’s cancer research and treatment centers; there are fewer than 40 in the United States. The designation signifies that the center has met the highest standards for depth and breadth of effort in the following categories of cancer research: basic, clinical, and prevention, control, behavioral and population-based. Furthermore, the designation signifies that the center exhibits a strong body of interactive research that bridges these scientific areas.

Beaumont Hospitals Community Clinical Oncology Program
https://www.beaumonthospitals.com/cancer/ccto
Since 1999, the Cancer Clinical Trials Office (CCTO) has been helping patients throughout Beaumont take part in state-of-the-art cancer research. In 2001, the office gained national recognition by becoming a Community Clinical Oncology Program (CCOP). Through the CCOP, clinical trials sponsored by the National Cancer Institute are made available to Beaumont patients. Currently, more than100 trials are available to patients dealing with cancers of the breast, lung, prostate, colon, brain, and skin (melanoma), as well as leukemias and lymphomas. The Beaumont Cancer Clinical Trials Office offers studies from several nationally recognized cooperative groups, including the Southwest Oncology Group; the National Surgical Breast and Bowel Project; and the American College of Surgical Oncology Group. Study coordinators work closely with the physicians who refer their patients for the trials. The team of cancer specialists includes medical oncologists, surgical oncologists, radiation oncologists, and pediatric hematologist / oncologists.

Grand Rapids Community Clinical Oncology Program
www.grcop.org
The Grand Rapids Clinical Oncology Program (GRCOP) is a community cancer research and education program offering national cancer prevention and treatment clinical trials for people who are at risk for developing cancer or who have been diagnosed with cancer. GRCOP, which is comprised of more than 300 western and northern Lower Michigan member physicians in more than 38 counties, is supported by funding from a National Cancer Institute Community Clinical Oncology Program grant and the following member hospitals and affiliates:

Michigan Cancer Research Consortium Community Clinical Oncology Program
www.mcrconline.org/about-mcrc/index.php
The Michigan Cancer Research Consortium CCOP is one of only 50 community-based research programs supported by the National Cancer Institute (NCI). The Community Clinical Oncology Program (CCOP) is a comprehensive clinical trials network for distributing the latest cancer prevention, control, symptom management, and treatment findings to the community level. Created in 1983 by the NCI, CCOP enables patients and physicians to participate in clinical trials at 61 major research centers in 34 states throughout the country, the District of Columbia, and Puerto Rico. Participation is limited to medical centers that have met the highest standards of excellence in conducting cancer clinical trials. There are only 50 such programs in the country sponsored by the NCI. The mission of the CCOP is to link patients in their communities with leading clinical cooperative groups and large cancer treatment centers located throughout the United States and Canada. These links provide state-of-the-art cancer treatments that can be offered through community hospitals.

West Michigan Cancer Center Community Clinical Oncology Program
www.wmcc.org/clinical_trials/index.php
West Michigan Cancer Center is the acknowledged regional leader in cancer treatment. For more than a decade, the West Michigan Cancer Center has offered innovative cancer treatment, therapies, and contemporary clinical procedures that are among the most advanced in west Michigan. Clinical trials are currently available through the West Michigan Cancer Center and affiliated resources.

Great Lakes Cancer Institute Academic Medical Center
www.glci.com/body.cfm?id=223
Michigan State University and McLaren Health Care formed and founded the Great Lakes Cancer Institute (GLCI) in 2001. Their vision and insight saw a future for mid-Michigan that included scientific cancer research, medical research, clinical trials, and the greatest minds, technology, people, and medical care. They envisioned hope for the advancement and treatment of cancer in their own communities. GLCI blends the resources of a Big Ten academic institution with the nation's 18th largest health care system. The result is a network of highly skilled, highly respected, physicians, scientists, researchers, and educators. Together, they represent a range of services, treatments, and clinical research, which previously was found only at traditional academic medical centers. The Institute’s vision is to demonstrate cancer leadership of national renown in our own communities; to provide the residents of Michigan with cancer information, education, and research; and ultimately, to translate research findings to patient care as rapidly as possible.

Josephine Ford Cancer Center Academic Medical Center
www.henryfordhealth.org/body.cfm?id=33751
Josephine Ford Cancer Center (JFCC) is the focus of all cancer-related activities within Henry Ford Health System. JFCC offers a blend of technology, teamwork and service, all marked by a commitment to excellence. JFCC is an international leader in the research, detection and treatment of cancer. The multidisciplinary program provides a full continuum of care that spans prevention, early diagnosis, and support programs, including palliative care. As a leader in cancer care, the center's expertise has touched lives beyond the southeast Michigan region. Today, physicians around the world offer diagnostic and treatment modalities that were pioneered at JFCC.

Clinical Trials Support Unit
www.ctsu.org
The Cancer Trials Support Unit (CTSU) is a pilot project sponsored by the National Cancer Institute (NCI) for the support of a national network of physicians to participate in NCI-sponsored Phase III cancer treatment trials. Its objectives are to:

Return to top of page
last updated: 02/03/08


Washington Square Building, 5th Floor · 109 Michigan Ave. · Lansing, Michigan USA 48913 Toll-Free: (877) 588-6224 · Fax: (517) 335-9397 ·

Tell us what you think about this Web site. Take our survey.

Copyright 2000-2008, Michigan Cancer Consortium

Editorial Policy · Disclaimer · Site Index